ロード中...
Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail
The GL261 cell line, syngeneic on the C57BL/6 background, has, since its establishment half a century ago in 1970, become the most commonly used immunocompetent murine model of glioblastoma. As immunotherapy has entered the mainstream of clinical discourse in the past decade, this model has proved i...
保存先:
| 出版年: | Neurooncol Adv |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209580/ https://ncbi.nlm.nih.gov/pubmed/34151268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab066 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|